Clinical Trial Update: Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients [NA]

View source ↗

Summary

A completed clinical trial evaluated post-operative intravenous ketorolac for GTPase inhibition in ovarian cancer patients. The study also included fallopian tu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Toradol (ketorolac tromethamine)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Ovarian Cancer, Fallopian Tube Cancer | NA | Status: COMPLETED